ARTICLE | Targets & Mechanisms
Seeing CNV sooner
June 25, 2009 7:00 AM UTC
New research by a multinational team suggests that noninvasive imaging of CC chemokine receptor 3 could help detect wet age-related macular degeneration before retinal damage occurs.1 This would allow earlier therapeutic intervention, which is important because retinal damage is not always reversible.
In addition, the researchers think CC chemokine receptor 3 (CCR3) inhibitors could be combined with VEGF-A inhibitors to treat the disease-even if the former are unlikely to displace the latter...